Home › Therapeutic areas › Cardiovascular › Hypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy (2 companies)
Companies with an active program in Hypertrophic Cardiomyopathy.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| EWTX | Edgewise Therapeutics | Cardiovascular | 2 | Phase 2 | $4.93B | 3 |
| LXEO | Lexeo Therapeutics | CardiovascularNeurology Rare | 1 | Phase 2 | $237M | 12 |
No companies match.